Cubist Systematic Strategies »

Entrada Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $712k 123k 5.80
2023-03-31 $60k 4.2k 14.50
2022-12-31 $5.5k 405 13.52
2022-09-30 $16k 1.0k 15.92
2022-06-30 $23k 1.9k 12.27
2021-12-31 $190k 11k 17.13

More positions owned by Cubist Systematic Strategies

Spdr Gold Tr Gold Shs (GLD)
Oracle Corporation Call Option (ORCL)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Palantir Technologies Cl A Call Option (PLTR)
UnitedHealth Call Option (UNH)
Robinhood Mkts Com Cl A Call Option (HOOD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Select Sector Spdr Tr Energy Call Option (XLE)
Nebius Group Shs Class A Call Option (NBIS)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Wal-Mart Stores (WMT)

View all positions for Cubist Systematic Strategies

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics